First Patient Treated in U.S. Clinical Trial of IDCT for Degenerative Disc Disease

DiscGenics Announces First Patient Treated in U.S. Clinical Trial of IDCT for Degenerative Disc Disease

SALT LAKE CITY, April 26, 2018 /PRNewswire/ — DiscGenics, Inc., a clinical stage regenerative medicine company focused on developing cell therapies that alleviate…